Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00068276 · ClinicalTrials.gov registry record · Phase 2
Cholecalciferol in Treating Patients With Myelodysplastic Syndrome
A Phase 2 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00068276: Completed Phase 2 study, sponsored by Wake Forest University Health Sciences.
NCT00068276 is a Phase 2 study that has completed, run by Wake Forest University Health Sciences. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00068276, a Phase 2 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Cholecalciferol (vitamin D) may improve quality of life by increasing blood counts, decreasing fatigue, and improving other symptoms of myelodysplastic syndrome. PURPOSE: This phase II trial is studying how well cholecalciferol works in treating patients with myelodysplastic syndrome.
Interventions
- DIETARY_SUPPLEMENT cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-07 |
| Est. Completion | 2006-09 |
| Phase | Phase 2 |
What the finished NCT00068276 record still lists
NCT00068276 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which cholecalciferol is the first listed.
NCT00068276 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00068276 about?
NCT00068276 is a clinical study titled "Cholecalciferol in Treating Patients With Myelodysplastic Syndrome". RATIONALE: Cholecalciferol (vitamin D) may improve quality of life by increasing blood counts, decreasing fatigue, and improving other symptoms of myelodysplastic syndrome. PURPOSE: This phase II trial is studying how well cholecalciferol works in treating patients with myelodysplastic syndrome.
What is the current status of trial NCT00068276?
This trial is currently completed. It is a Phase 2 study. The study started on 2003-07. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00068276?
The interventions under investigation include: cholecalciferol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00068276?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia